SCHEMBL11299163

SCHEMBL11299163

O=C(NO)c1ccc(N(c2ccccc2Cl)C2CCNC2=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 11/20 0.40
▸ HDAC8 Q9BY41 9/20 0.40
▸ HDAC1 Q13547 9/20 0.39
▸ HDAC2 Q92769 2/20 0.36
▸ PSEN1 P49768 2/20 0.34
▸ PSEN2 P49810 2/20 0.34
▸ APH1B Q8WW43 2/20 0.34
▸ NCSTN Q92542 2/20 0.34
▸ APH1A Q96BI3 2/20 0.34
▸ PSENEN Q9NZ42 2/20 0.34
▸ ALOX15 P16050 2/20 0.34
▸ HDAC3 O15379 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ IDO1 P14902 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ HDAC7 Q8WUI4 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ NCOR2 Q9Y618 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301790 0.91 HDAC6 (0.36) HDAC6HDAC8HDAC1HDAC2PSEN1
SCHEMBL11301603 0.88 HDAC6 (0.38) HDAC6HDAC8HDAC1HDAC2PSEN1
SCHEMBL11300535 0.87 HDAC8 (0.39) HDAC6HDAC8HDAC1HDAC2HDAC3
SCHEMBL11304464 0.87 HDAC8 (0.37) HDAC6HDAC8HDAC1PSEN1PSEN2
SCHEMBL11303351 0.87 HDAC6 (0.40) HDAC6HDAC8HDAC1HDAC2ALOX15
SCHEMBL11301754 0.85 PSEN1 (0.42) HDAC6HDAC8HDAC1HDAC2PSEN1
SCHEMBL11296122 0.85 HDAC6 (0.43) HDAC6HDAC8HDAC1HDAC2HDAC3
SCHEMBL11296595 0.83 HDAC6 (0.42) HDAC6HDAC8HDAC1HDAC2PSEN1
SCHEMBL11303328 0.82 HDAC8 (0.37) HDAC6HDAC8HDAC1PSEN1PSEN2
SCHEMBL11301770 0.82 PSEN1 (0.38) HDAC6HDAC8HDAC1PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback